Trifluoperazine Synergistically Potentiates Bortezomib-Induced Anti-Cancer Effect in Multiple Myeloma via Inhibiting P38 MAPK/NUPR1
Zizi Jing et al, 2022, Tohoku J. Exp. Med. CrossRef